Thyroid Stimulating Immunoglobulin: An Overview, Main Clinical Uses, and its Impact on Patient Care
Watch now
In this presentation, we will offer a clinical overview of the Thyroid Stimulating Immunoglobulin (TSI) assay. We will discuss unique aspects of this analyte, differences from other thyroid markers, and focus on its clinical importance and how TSI measurements offered by laboratories are critical in optimizing the care and patient outcomes in thyroid diseases.
This presentation is a unique opportunity for laboratory professionals to gain an in-depth look at the importance of their work providing accurate TSI results to clinicians, learning directly from the perspective of a leading endocrinologist at the Cleveland Clinic.
Key learning objectives
By the end of this presentation, participants will be able to:
- Differentiate TSI from other thyroid biomarkers reported by the laboratory
- List multiple thyroid disorders where TSI measurement is warranted
- Discuss how TSI results impact patient care, enabling more efficient communication with clinicians in their institutions
Who should attend
- Clinicians
- Laboratorians
- Specialists
- HCPs
Accreditation statement
SelectScience is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. Attendees of this one-hour webinar are also entitled to 1.0 ACCENT Continuing Education Credits from the ADLM. This activity was planned in accordance with ACCENT® Standards and Policies. Verification of Participation certificates are provided to registered participants based on completion of the activity, in its entirety, and the activity evaluation. For questions regarding continuing education, please email education@myadlm.org.
Certificate of attendance
A certificate of attendance is available for webinar viewers. To request yours, email editor@selectscience.net after viewing the webinar.
Webinar details
- Cost: Free to attend
- Location: Online
- Duration: 60 minutes
Missed the live event?
Register now to access the full webinar and hear all the insights shared during the discussion.
Speakers
Moderator
Featured products
Request Quote for All Products
IMMULITE 2000/2000 XPi TSI Assay
Siemens HealthineersThe IMMULITE 2000/2000 XPi TSI assay detects thyroid stimulating antibodies, the specific cause of GD pathology, with a clinical sensitivity and specificity of 98.6% and 98.5% respectively. With a 65-minute total assay time and ready-to-use, stable reagents, the use of this assay can make the differential diagnosis of GD faster and easier, allowing patients to be diagnosed and treated sooner.
What will this webinar cover?
Join the webinar to get answers to these questions:
- How does Thyroid Stimulating Immunoglobulin (TSI) differ from other thyroid biomarkers?
- In which thyroid disorders is TSI measurement clinically warranted?
- How do TSI results guide diagnosis and management of Graves’ and other thyroid diseases?
- How can laboratorians communicate TSI findings more effectively with clinicians?
- Why are accurate TSI assays critical for optimizing thyroid patient outcomes?